Name | Title | Contact Details |
---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Southside Medical Center is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Trailblazer Health Enterprises, LLC is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Nexus Communications is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hugh Chatham Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Hugh Chatham Memorial Hospital is based in Elkin, NC. You can find more information on Hugh Chatham Memorial Hospital at www.hughchatham.org